- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PF-02341066/PF-00299804
Total 1291 results
-
Seoul National University HospitalPfizerCompletedAdvanced Gastric Cancer | HER2Korea, Republic of
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
PfizerCompletedNeoplasm Metastasis | Carcinoma, Non-Small CellUnited States, France, Spain
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
University Health Network, TorontoPfizerCompleted
-
University Health Network, TorontoPfizerCompletedHead and Neck Squamous Cell CarcinomaCanada
-
PfizerTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
PfizerCompleted
-
PfizerCompletedNeoplasmsUnited States, Netherlands
-
Yonsei UniversityCompletedHead Neck Cancer Squamous Cell Recurrent | Head Neck Cancer Squamous Cell MetastaticKorea, Republic of
-
PfizerCompleted
-
NCIC Clinical Trials GroupPfizerCompletedLung CancerTaiwan, Canada, Australia, Italy, New Zealand, United States, Thailand, Korea, Republic of, Brazil, Argentina, Philippines, Peru
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...PfizerCompletedCarcinoma, Squamous Cell | Penile NeoplasmsItaly
-
PfizerCompletedCarcinoma, Non-small CellUnited States, Taiwan, Korea, Republic of, Japan, Hong Kong
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...UnknownSkin Squamous Cell CancerItaly
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
PfizerCompleted
-
National Cancer Institute (NCI)TerminatedAdenocarcinoma | Carcinoma, Squamous Cell | Carcinoma, Non-Small Cell Lung | Carcinoma, Large CellUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingStage IB Non-Small Cell Lung Carcinoma AJCC v7 | Stage II Non-Small Cell Lung Cancer AJCC v7 | Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | ALK Gene Rearrangement | ALK Gene Translocation | ALK...United States, Guam, Puerto Rico
-
PfizerCompletedNon Small Cell Lung CancerUnited States, Australia
-
PfizerCompletedCarcinoma, Non Small Cell LungUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI); PfizerCompletedRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Childhood Anaplastic Large Cell LymphomaUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Brigham and Women's Hospital; Henry Ford...CompletedGlioblastoma | Glioblastoma Multiforme | GBMUnited States
-
PfizerCompletedCarcinoma, Non Small Cell LungKorea, Republic of
-
Grupo Español de Investigación en NeurooncologíaPfizerCompleted
-
PfizerRoswell Park Cancer Institute; South Texas Accelerated Research Therapeutics...CompletedAdvanced Malignant Solid TumorsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
University Health Network, TorontoCompletedSquamous Cell Carcinoma of the Head and NeckCanada
-
PfizerCompletedNon-Small Cell Lung CancerUnited States, Korea, Republic of, United Kingdom, Greece, Slovakia, France, Belgium, Ireland, Japan, Spain, China, Sweden, India, Hungary, Switzerland, Russian Federation, Germany, Mexico, Denmark, Austria, Finland, Poland, South Africa
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | BRAF Gene MutationUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung CancerUnited States
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Australia, Japan, Korea, Republic of, Spain
-
PfizerCompleted
-
PfizerCompletedHealthy VolunteerUnited States
-
PfizerCompleted
-
Rottapharm SpainCompletedParkinson's Disease, IdiopathicSpain
-
University of FloridaCompletedGastrointestinal Symptoms | Stool Frequency | Gastrointestinal Transit TimeUnited States
-
PfizerCompleted
-
PfizerCompletedSchizophreniaUnited States
-
PfizerCompleted
-
European Organisation for Research and Treatment...PfizerCompletedLocally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma | Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor | Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 | Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma | Locally Advanced... and other conditionsFrance, Belgium, Netherlands, Germany, United Kingdom, Italy, Norway, Poland, Slovakia, Slovenia
-
PfizerCompleted
-
PfizerCompleted
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingUnresectable Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell Carcinoma | Metastatic Papillary Renal Cell Carcinoma | Locally Advanced Papillary Renal Cell CarcinomaUnited States, Canada
-
PfizerCompleted